About The Study: Amid a rising trend of conservative management for prostate cancer, this study found a significant increase in initial active surveillance and watchful waiting for intermediate–risk prostate cancer between 2010 and 2020. This corresponds with evidence of favorable longer-term outcomes and improvements in staging imaging and risk stratification.
Corresponding Author: To contact the corresponding author, Michael S. Leapman, MD, MHS, email michael.leapman@yale.edu .
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.20580)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.20580?guestAccessKey=076ede4e-9f05-459b-aeef-3f311f77ce82&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112024
JAMA